GIL · Gildan Activewear, Inc.
$49.60
+0.84% last session
End-of-day data · updated 2026-07-25
Market cap
$9B
Enterprise value
$14B
Trailing P/E
29.0
Forward P/E
9.3
Dividend yield
2.0%
Beta
1.12
Avg volume
2M
Employees
75K
2D change
0.71%
5D change
-8.42%
10D change
-4.77%
30D change
-6.60%
60D change
-16.57%
MTD change
-3.27%
YTD change
-19.32%
Analyst Outlook
Analyst estimates change daily — follow the shifts on the Estimate Trends page.
Technical Analysis
Analyst sentiment over time — GIL
Rec Mean (blue, left — higher = more bullish) vs. price targets (right).
Investment Bank Ratings as of 2026-06-17
Latest call per bank · past 12 months
RBC Capital
Outperform$78.00
+57.3% vs priceUBS
Buy$110
+121.8% vs priceBarclays
Overweight$70.00
+41.1% vs priceCitigroup
Neutral$63.00
+27.0% vs priceRecent rating actions
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-06-17 | Scotiabank | Maintains | Sector Outperform | $72.00 → $65.00 |
| 2026-05-04 | Scotiabank | Maintains | Sector Outperform | $74.00 → $72.00 |
| 2026-03-02 | Scotiabank | Maintains | Sector Outperform | $72.00 → $74.00 |
| 2026-03-02 | RBC Capital | Maintains | Outperform | $79.00 → $78.00 |
| 2026-02-24 | RBC Capital | Maintains | Outperform | $71.00 → $79.00 |
| 2026-02-03 | Scotiabank | Maintains | Sector Outperform | $66.00 → $72.00 |
| 2026-01-26 | BMO Capital | Maintains | Outperform | $70.00 → $78.00 |
| 2025-12-16 | UBS | Maintains | Buy | $80.00 → $110 |
Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.
Signal Summary as of 2026-07-27
- RSI (14): RSI is 39 — neutral momentum, neither overbought nor oversold.
- Price vs 50-day MA: Trading 9.2% below the 50-day MA ($55.05).
- Price vs 200-day MA: Trading 15.8% below the 200-day MA ($59.40).
- MA cross: The 50-day MA sits below the 200-day MA (death-cross regime) — the longer-term trend points down.
- MACD (12,26,9): MACD histogram is positive (+0.01) — short-term momentum is improving.
- 52-week range: Price is within 10% of the 52-week low ($48.49).
GIL Price Chart
Loading chart for GIL…
Fundamentals
About Gildan Activewear, Inc.
Gildan Activewear Inc. manufactures and sells various apparel products. The company provides various activewear products, including T-shirts, fleece tops and bottoms, sports shirts, polos, and tank tops under Gildan, Hanes, Gildan Performance, Gildan Hammer, Gildan Softstyle, Gildan Heavy Cotton, Gildan Ultra Cotton, Gildan DryBlend, Gildan HeavyBlend, Comfort Colors, American Apparel, ALLPRO, ComfortWash, BEEFY, Bonds and Champion brands. It also offers hosiery products comprising athletic, dress, casual and workwear socks, liner socks, and socks for therapeutic purposes under Gildan, GoldToe, Signature Gold by GoldToe, GoldToe Edition, Peds, MediPeds, Hanes, and Powersox brands. In addition, the company provides men's and boys' underwear products and ladies' panties under Gildan, Gildan Platinum, Gildan Softstyle, Gildan Performance, BareSoft, Gildan Performance, EZBreeze, Bonds, Berlei, Bras N Things, Polo Ralph Lauren brands. Further, it provides women's lingerie, bras and shapewear under Bali, Playtex, WonderBra, Maidenform, Bonds, Bras N Things, Berle brands. It sells its products to wholesale distributors, screenprinters, and embellishers in North America, Europe, the Asia-Pacific, and Latin America, as well as to retailers in North America, including mass merchants, department stores, national chains, specialty retailers, craft stores, and online retailers; and manufactures products for lifestyle brand companies. The company was formerly known as Textiles Gildan Inc. and changed its name to Gildan Activewear Inc. in March 1995. Gildan Activewear Inc. was founded in 1946 and is headquartered in Montreal, Canada.
More in Apparel Manufacturing
Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.